LNTH - Lantheus Holdings Inc Stock Price, Fair Value and News

74.94USD-1.07 (-1.41%)Delayed as of 08 May 2024, 01:03 pm ET

Market Summary

USD74.94-1.07

Delayedas of 08 May 2024, 01:03 pm

-1.41%

LNTH Alerts

Big jump in Earnings (Y/Y)

LNTH Stock Price

View Fullscreen

LNTH RSI Chart

LNTH Valuation

Market Cap

5.3B

Price/Earnings (Trailing)

11.44

Price/Sales (Trailing)

3.86

EV/EBITDA

7.58

Price/Free Cashflow

16.26

LNTH Price/Sales (Trailing)

LNTH Profitability

EBT Margin

43.45%

Return on Equity

48.71%

Return on Assets

25.15%

Free Cashflow Yield

6.15%

LNTH Fundamentals

LNTH Revenue

Revenue (TTM)

1.4B

Rev. Growth (Yr)

23%

Rev. Growth (Qtr)

4.51%

LNTH Earnings

Earnings (TTM)

460.5M

Earnings Growth (Yr)

4.8K%

Earnings Growth (Qtr)

26.78%

Breaking Down LNTH Revenue

52 Week Range

59.85100.85

(Low)(High)

Last 7 days

14.2%

Last 30 days

25.0%

Last 90 days

39.2%

Trailing 12 Months

-19.8%

How does LNTH drawdown profile look like?

LNTH Financial Health

Current Ratio

4.84

Debt/Equity

0.59

Debt/Cashflow

0.58

LNTH Investor Care

Shares Dilution (1Y)

1.43%

Diluted EPS (TTM)

6.56

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.4B	0	0	0
2023	1.0B	1.1B	1.2B	1.3B
2022	541.6M	664.2M	801.5M	935.1M
2021	341.2M	376.3M	389.8M	425.2M
2020	351.5M	331.8M	334.6M	339.4M
2019	347.3M	347.4M	344.3M	347.3M
2018	332.6M	329.4M	338.3M	343.4M
2017	306.7M	317.6M	324.5M	331.4M
2016	295.1M	299.8M	298.7M	301.9M
2015	303.1M	300.8M	299.2M	293.5M
2014	0	289.6M	295.6M	301.6M
2013	0	0	0	283.7M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Lantheus Holdings Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 17, 2024	niedzwiecki daniel	sold (taxes)	-10,882	61.48	-177	see remarks
Apr 17, 2024	blanchfield paul	sold (taxes)	-27,973	61.48	-455	president
Apr 15, 2024	sabens andrea	sold	-20,882	61.24	-341	chief accounting officer
Mar 15, 2024	marshall robert j. jr.	sold	-1,200,000	60.00	-20,000	cfo and treasurer
Mar 13, 2024	sabens andrea	sold	-20,623	60.48	-341	chief accounting officer
Mar 07, 2024	blanchfield paul	sold	-1,116,710	61.96	-18,023	president
Mar 07, 2024	blanchfield paul	gifted	-	-	-500	president
Mar 06, 2024	leno sam r	sold	-129,857	63.4999	-2,045	-
Mar 06, 2024	leno sam r	acquired	33,333	16.3	2,045	-
Mar 05, 2024	leno sam r	sold	-132,148	64.6199	-2,045	-

Which funds bought or sold LNTH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	LSV ASSET MANAGEMENT	added	72.99	13,234,000	31,201,000	0.06%
May 06, 2024	Envestnet Portfolio Solutions, Inc.	added	8.97	28,693	334,167	-%
May 06, 2024	Parallel Advisors, LLC	added	937	15,753	17,427	-%
May 06, 2024	SG Americas Securities, LLC	reduced	-17.17	-47,000	235,000	-%
May 06, 2024	Empowered Funds, LLC	new	-	2,357,780	2,357,780	0.04%
May 06, 2024	Gallacher Capital Management LLC	new	-	400,701	400,701	0.20%
May 06, 2024	Candriam S.C.A.	reduced	-15.8	-4,636,510	25,316,300	0.16%
May 06, 2024	Advisory Services Network, LLC	sold off	-100	-21,700	-	-%
May 06, 2024	TEACHER RETIREMENT SYSTEM OF TEXAS	added	105	772,000	1,501,000	0.01%
May 06, 2024	Savant Capital, LLC	new	-	226,803	226,803	-%

Are Funds Buying or Selling LNTH?

Are funds buying LNTH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LNTH

No. of Funds

LNTH Alerts

Big jump in Earnings (Y/Y)

Unveiling Lantheus Holdings Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	janus henderson group plc	5.8%	3,962,606	SC 13G
Feb 13, 2024	vanguard group inc	10.18%	6,973,141	SC 13G/A
Jan 23, 2024	blackrock inc.	12.6%	8,600,964	SC 13G/A
Feb 10, 2023	blackrock inc.	11.9%	8,213,720	SC 13G/A
Feb 09, 2023	vanguard group inc	10.53%	7,247,124	SC 13G/A
Jan 26, 2023	blackrock inc.	11.9%	8,203,470	SC 13G/A
Jan 20, 2023	blackrock inc.	11.9%	8,203,470	SC 13G/A
Jul 11, 2022	vanguard group inc	10.84%	7,438,724	SC 13G/A
Feb 15, 2022	armistice capital, llc	0%	0	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	3.1%	2,165,371	SC 13G/A

Recent SEC filings of Lantheus Holdings Inc

View All Filings

Date Filed	Form Type	Document
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 29, 2024	8-K	Current Report
Apr 26, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 17, 2024	4	Insider Trading
Apr 15, 2024	144	Notice of Insider Sale Intent
Apr 04, 2024	3	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 15, 2024	ARS	ARS

Peers (Alternatives to Lantheus Holdings Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	357.8B	85.6B	-2.43%	-8.39%	9.3	4.18	5.68%	202.39%
MRK	330.2B	61.4B	1.86%	10.13%	143.19	5.38	6.11%	-82.30%
AMGN	161.1B	29.5B	11.28%	28.04%	42.82	5.46	12.76%	-52.47%
PFE	156.8B	46.5B	4.16%	-28.19%	-112.94	3.37	42.59%	-114.62%
GILD	81.5B	27.1B	-5.96%	-16.75%	14.39	3.01	-0.60%	23.36%
TEVA	15.6B	15.8B	-2.04%	54.08%	-27.14	0.99	6.17%	76.47%
MID-CAP
ALKS	4.2B	1.7B	-5.86%	-20.45%	9.58	2.41	54.01%	364.56%
PRGO	4.1B	4.6B	-3.95%	-16.22%	-533.77	0.9	-0.06%	94.55%
BHC	2.7B	9.0B	-28.82%	23.71%	-5.97	0.3	10.01%	-27.45%
AMPH	2.1B	644.4M	2.42%	17.52%	14.96	3.19	29.14%	50.51%
SMALL-CAP
TLRY	1.5B	743.2M	-23.46%	-28.42%	-4.38	2.07	24.65%	80.36%
TXMD	23.2M	1.3M	-9.05%	-48.20%	-2.26	17.8	-98.14%	-109.18%
ACRX	17.0M	-	-15.25%	35.14%	-0.92	0.22	2882.68%	-138.52%
AGRX	2.7M	19.6M	31.03%	-94.02%	-0.19	0.14	80.00%	43.08%
ACOR	1.1M	117.6M	-57.29%	-90.96%	0	0.01	-0.79%	-283.60%

Lantheus Holdings Inc News

Latest updates

Lantheus Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	4.5%	370	354	320	322	301	263	239	224	209	130	102	101	93.00	94.00	89.00	66.00	91.00	89.00	86.00	86.00	87.00
Gross Profit	5.2%	242	230	200	203	77.00	167	147	138	129	58.00	43.00	46.00	41.00	39.00	36.00	26.00	38.00	45.00	42.00	45.00	44.00
S&GA Expenses	29.2%	46.00	35.00	37.00	36.00	33.00	27.00	25.00	27.00	20.00	19.00	17.00	18.00	14.00	13.00	12.00	6.00	10.00	10.00	10.00	11.00	10.00
R&D Expenses	185.4%	48.00	17.00	14.00	16.00	31.00	272	13.00	15.00	12.00	11.00	11.00	12.00	10.00	13.00	12.00	4.00	4.00	4.00	5.00	6.00	5.00
EBITDA Margin	30.3%	0.49*	0.38*	0.14*	0.08*	0.02*	0.09*	0.27*	0.17*	0.04*	-0.06*	0.03*	0.05*	-	-	-	-	-	-	-	-	-
Interest Expenses	-3.6%	5.00	5.00	5.00	5.00	5.00	3.00	2.00	1.00	2.00	2.00	2.00	2.00	3.00	3.00	3.00	2.00	2.00	2.00	2.00	5.00	5.00
Income Taxes	14.8%	40.00	35.00	28.00	30.00	-8.30	-57.06	22.00	19.00	15.00	-0.79	-6.42	-1.88	5.00	1.00	-1.08	0.00	2.00	-8.05	1.00	2.00	3.00
Earnings Before Taxes	23.7%	171	138	160	124	-11.10	-176	83.00	62.00	58.00	-41.01	-19.84	-28.54	14.00	-2.84	-7.46	-6.70	6.00	2.00	5.00	8.00	13.00
EBT Margin	37.1%	0.43*	0.32*	0.08*	0.02*	-0.04*	0.03*	0.20*	0.09*	-0.06*	-0.18*	-0.09*	-0.07*	-	-	-	-	-	-	-	-	-
Net Income	26.8%	131	103	132	94.00	-2.81	-119	61.00	43.00	43.00	-40.22	-13.41	-26.66	9.00	-3.41	-6.39	-7.01	3.00	10.00	5.00	6.00	10.00
Net Income Margin	33.8%	0.34*	0.25*	0.09*	0.03*	-0.02*	0.03*	0.13*	0.05*	-0.07*	-0.17*	-0.09*	-0.07*	-	-	-	-	-	-	-	-	-
Free Cashflow	13.3%	127	112	117	-32.27	109	105	94.00	73.00	10.00	14.00	4.00	26.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	10.9%	1,831	1,651	1,522	1,338	1,349	1,321	1,096	1,014	933	864	848	858	843	870	880	880	404	406	402	390	444
Current Assets	5.8%	1,149	1,086	948	752	773	678	502	404	325	236	202	186	168	184	185	181	180	173	154	140	195
Cash Equivalents	0.9%	720	714	614	414	471	416	257	171	105	99.00	91.00	92.00	69.00	83.00	88.00	90.00	96.00	93.00	78.00	57.00	112
Inventory	8.9%	70.00	64.00	56.00	52.00	42.00	35.00	35.00	34.00	34.00	35.00	34.00	32.00	30.00	36.00	38.00	35.00	31.00	29.00	31.00	32.00	32.00
Net PPE	2.3%	150	147	-	-	-	-	-	-	-	-	-	-	-	-	-	-	109	116	114	113	112
Goodwill	0%	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	59.00	58.00	45.00	16.00	16.00	16.00	16.00	16.00
Liabilities	6.1%	886	835	823	785	904	874	458	446	417	399	348	350	315	356	366	364	286	291	301	298	361
Current Liabilities	26.6%	237	187	177	154	276	248	236	219	178	90.00	77.00	74.00	65.00	81.00	82.00	76.00	62.00	66.00	60.00	53.00	43.00
Long Term Debt	0.1%	562	562	561	559	559	558	152	156	159	163	167	169	171	198	205	210	181	184	186	189	263
LT Debt, Current	-10.8%	1.00	1.00	1.00	0.00	0.00	0.00	15.00	14.00	13.00	12.00	10.00	10.00	10.00	21.00	18.00	17.00	10.00	10.00	10.00	10.00	3.00
LT Debt, Non Current	-	-	-	-	-	-	558	-	-	-	163	-	-	171	198	205	210	181	184	186	189	263
Shareholder's Equity	15.9%	946	816	699	553	446	447	638	567	516	464	499	508	528	514	514	516	118	115	101	92.00	83.00
Retained Earnings	98.2%	265	134	30.00	-101	-195	-193	-73.97	-135	-178	-221	-181	-167	-140	-149	-146	-140	-133	-136	-146	-151	-158
Additional Paid-In Capital	-0.2%	756	758	744	730	717	716	708	700	692	685	681	676	670	666	662	658	254	252	249	245	242
Shares Outstanding	1.1%	71.00	70.00	70.00	70.00	70.00	69.00	69.00	68.00	68.00	67.00	68.00	68.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	5,673	-	-	-	4,487	-	-	-	1,850	-	-	-	947	-	-	-	1,091	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	13.3%	127,238	112,287	116,739	-32,266	108,500	105,352	93,568	72,597	10,264	13,889	4,340	25,869	9,818	569	8,575	-2,156	9,408	22,421	26,442	21,053	10,468
Share Based Compensation	8.6%	15,384	14,172	13,976	12,692	9,667	8,124	8,103	7,412	5,623	4,162	3,867	4,588	3,317	3,623	3,992	3,385	3,075	2,991	3,423	3,358	2,720
Cashflow From Investing	-782.7%	-106,529	-12,069	83,218	-20,697	-44,513	-264,724	-6,090	-4,343	-1,390	-4,544	-2,420	-2,656	13,303	-3,785	-3,736	5,307	-2,698	-4,741	-3,336	-3,434	-10,550
Cashflow From Financing	-3643.3%	-16,845	-450	108	-4,051	-8,669	317,840	-1,959	-2,011	-2,179	-2,100	-1,726	-715	-34,791	-4,373	-7,270	-6,486	-3,732	-2,823	-1,900	-72,927	-1,231

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

LNTH Income Statement

2024-03-31

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 369,975	$ 300,784
Cost of goods sold	128,129	223,708
Gross profit	241,846	77,076
Operating expenses
Sales and marketing	45,546	32,617
General and administrative	47,895	23,271
Research and development	48,024	30,532
Total operating expenses	141,465	86,420
Gain on sale of assets	6,254	0
Operating income (loss)	106,635	(9,344)
Interest expense	4,859	4,991
Investment in equity securities - unrealized gain	60,704	0
Other income	(8,788)	(3,231)
Income (loss) before income taxes	171,268	(11,104)
Income tax expense (benefit)	40,202	(8,297)
Net income (loss)	$ 131,066	$ (2,807)
Net income (loss) per common share:
Basic (in dollars per share)	$ 1.91	$ (0.04)
Diluted (in dollars per share)	$ 1.87	$ (0.04)
Weighted-average common shares outstanding:
Basic (in shares)	68,757	67,749
Diluted (in shares)	70,095	67,749

LNTH Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 718,279	$ 713,656
Accounts receivable, net	337,389	284,292
Inventory	69,758	64,029
Other current assets	16,215	16,683
Assets held for sale	7,159	7,159
Total current assets	1,148,800	1,085,819
Investment in equity securities	138,960	0
Property, plant and equipment, net	150,090	146,697
Intangibles, net	142,054	151,985
Goodwill	61,189	61,189
Deferred tax assets, net	138,898	150,198
Other long-term assets	51,343	55,261
Total assets	1,831,334	1,651,149
Current liabilities
Current portion of long-term debt and other borrowings	734	823
Accounts payable	37,525	41,189
Accrued expenses and other liabilities	198,939	145,338
Total current liabilities	237,198	187,350
Asset retirement obligations	23,023	22,916
Long-term debt, net and other borrowings	562,466	561,670
Other long-term liabilities	63,107	63,321
Total liabilities	885,794	835,257
Commitments and contingencies (See Note 18)
Stockholders’ equity
Preferred stock ($0.01 par value, 25,000 shares authorized; no shares issued and outstanding)	0	0
Common stock ($0.01 par value, 250,000 shares authorized; 70,635 and 69,863 shares issued as of March 31, 2024 and December 31, 2023, respectively)	706	699
Additional paid-in capital	756,443	757,727
Treasury Stock at cost - 1,339 shares as of March 31, 2024 and December 31, 2023	(75,000)	(75,000)
Retained earnings	264,569	133,503
Accumulated other comprehensive loss	(1,178)	(1,037)
Total stockholders’ equity	945,540	815,892
Total liabilities and stockholders’ equity	$ 1,831,334	$ 1,651,149

About Lantheus Holdings Inc

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; and Cardiolite, an injectable Tc-99m-labeled imaging agent. The company also offers AZEDRA, a radiotherapeutic therapy; Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; PNT2002 for pre-chemotherapy patients; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; and PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer. The company serves hospitals, independent diagnostic testing facilities, government facilities, integrated delivery networks, radiopharmacies, clinics, distirbutors, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; and FUJIFILM. The company was founded in 1956 and is based in Bedford, Massachusetts.

CEO	Ms. Mary Anne Heino
WEBSITE	lantheus.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	698

Lantheus Holdings Inc Frequently Asked Questions

What is the ticker symbol for Lantheus Holdings Inc? What does LNTH stand for in stocks?

LNTH is the stock ticker symbol of Lantheus Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lantheus Holdings Inc (LNTH)?

As of Tue May 07 2024, market cap of Lantheus Holdings Inc is 5.27 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LNTH stock?

You can check LNTH's fair value in chart for subscribers.

What is the fair value of LNTH stock?

You can check LNTH's fair value in chart for subscribers. The fair value of Lantheus Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Lantheus Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LNTH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Lantheus Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether LNTH is over valued or under valued. Whether Lantheus Holdings Inc is cheap or expensive depends on the assumptions which impact Lantheus Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LNTH.

What is Lantheus Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, LNTH's PE ratio (Price to Earnings) is 11.44 and Price to Sales (PS) ratio is 3.86. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LNTH PE ratio will change depending on the future growth rate expectations of investors.